Elecsys Folate III
Acid, Folic, Radioimmunoassay. 510(k) K233060, from Roche Diagnostics (Indianapolis, IN). Product code CGN, class 2.
As of Nov 19, 2026, K233060 is an FDA 510(k) held by Roche Diagnostics, substantially equivalent on Jun 17, 2024 after 266 days, with no recalls tied to it in FDA's recall database.
- Review time: 266 days
- Recalls: 0
Binding assay for the in vitro quantitative determination of folate in erythrocytes (red blood cells, RBC). Folate measurements are used in the diagnosis and treatment of anemia. The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.
- Roche Elecsys Folate Rbc; Roche Elecsys Folate Rbc CalsetK103716 · Roche Diagnostics · May 12, 2011
- Access Folate AssayK223590 · Beckman Coulter, Inc. · Aug 23, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 25, 2023
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1295
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files